Patients with glioma exhibiting elevated GNG5 expression have a shorter survival time [72], and patients with head and neck squamous cell carcinoma and elevated PRELID2 expression have a poor prognosis [73]. This evidence concerns the gene PRELID2 and head and neck squamous cell carcinoma.